UROLOGY · CONDITIONS
Prostate Cancer
The most common cancer in men , highly curable when detected early, requiring a personalised multidisciplinary approach from diagnosis through to definitive treatment.
ABOUT THIS CONDITION
What is Prostate Cancer?
Prostate cancer develops in the prostate gland and often grows slowly. Early disease is asymptomatic , making PSA screening critical. Advanced disease causes urinary obstruction, bone pain, and systemic illness. Treatment ranges from active surveillance for low-risk disease to robotic radical prostatectomy for localised cancer. Dr. Vipin provides the complete prostate cancer pathway , PSA evaluation, biopsy, staging, nerve-sparing radical prostatectomy, and long-term PSA monitoring , coordinated with oncology for a truly personalised treatment plan.
SIGNS TO WATCH
Common Symptoms
Symptoms that need attention
WHY IT HAPPENS
Causes & Risk Factors
- Ageing , risk rises sharply after 50
- Family history of prostate or breast cancer
- BRCA1/BRCA2 gene mutations
- African or Caribbean ethnic background
- High-fat, low-vegetable Western diet
- Hormonal factors , testosterone, IGF-1
CLINICAL DETAILS
KeyFacts
Annual PSA from age 50 (45 with family history). Early detection is life-saving.
Transperineal or TRUS biopsy with MRI fusion for accurate Gleason grading and staging.
RARP provides the best balance of oncological control, continence, and erectile function.
Preservation of neurovascular bundles maintains erectile function in appropriate cases.
Post-operative PSA detects biochemical recurrence early , measured 3 monthly for 2 years.
5-year survival exceeds 98% for localised prostate cancer treated with curative intent.
HOW WE TREAT IT
Treatment Approach
Robotic Radical Prostatectomy (RARP)
Robot-assisted laparoscopic removal of the prostate and seminal vesicles , the gold standard for localised prostate cancer, offering nerve-sparing precision, minimal blood loss, and fastest continence recovery.
- 1
PSA & Biopsy
PSA, digital rectal examination, and MRI-targeted prostate biopsy confirm diagnosis and determine Gleason grade and extent of disease.
- 2
Staging
PSMA PET-CT or bone scan and CT chest-abdomen-pelvis exclude nodal and distant metastases before surgery is planned.
- 3
Radical Prostatectomy
RARP, laparoscopic, or open radical prostatectomy removes the prostate and seminal vesicles. Nerve-sparing technique used where oncologically safe.
- 4
PSA Follow-up
Undetectable PSA at 6 weeks confirms surgical cure. PSA is monitored 3 monthly for 2 years, then 6 monthly thereafter for early detection of recurrence.
AVAILABLE TREATMENTS
Treatment Options
Robotic Radical Prostatectomy (RARP)
Robot-assisted minimally invasive prostatectomy , best oncological outcomes with fastest continence recovery and nerve preservation.
Laparoscopic Radical Prostatectomy
Minimally invasive laparoscopic removal of the prostate , equivalent oncological outcomes to open surgery with reduced blood loss.
Open Radical Prostatectomy
Retropubic open prostatectomy , the established technique with direct tactile access and wide surgical field for complex cases.
Bilateral Orchiectomy (androgen deprivation)
Surgical castration providing immediate, permanent testosterone suppression for advanced or metastatic prostate cancer.
Pelvic Lymph Node Dissection (PLND)
Extended pelvic lymphadenectomy performed at prostatectomy for accurate nodal staging and therapeutic debulking in node-positive disease.
TURP (palliative)
Palliative endoscopic resection of obstructing prostate cancer tissue to relieve urinary retention in advanced, non-curative disease.
Common Questions
Frequently Asked Questions
Not sure about your condition?
Compassionate, confidential consultations — Book your appointment today.